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Abstract 
Biotin is an essential vitamin in plants and mammals functioning as the carbon dioxide carrier 
within central lipid metabolism. Bacterial pimeloyl-CoA synthetase (BioW) acts as a highly 
specific substrate selection gate ensuring the integrity of the carbon chain in biotin synthesis. 
BioW catalyses the condensation of pimelic acid (C7 dicarboxylic acid) with CoASH in an 
ATP dependent manner to form pimeloyl-CoA, the first dedicated biotin building block. 
Multiple structures of Bacillus subtilis BioW together capture all three substrates as well as the 
intermediate pimeloyl-adenylate and product pyrophosphate (PPi), and indicates that the 
enzyme uses an internal ruler to select the correct dicarboxylic acid substrate. Both the catalytic 
mechanism and the surprising stability of the adenylate intermediate were rationalized through 
site-directed mutagenesis. Building on this understanding, BioW was engineered to synthesise 
high value heptanoyl (C7) and octanoyl (C8) mono carboxylic acid-CoA and C8 dicarboxylic-
CoA products, highlighting the enzyme’s synthetic potential. 
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INTRODUCTION 
In fatty acid biosynthesis biotin is an essential carbon dioxide carrier cofactor within large 
enzyme complexes, such as acetyl-CoA carboxylase (ACC), that catalyse carboxylation of 
acetyl-CoA to form malonyl-CoA 1. Biotin (Fig. 1a) possesses two fused rings (ureido and 
thiophane) whose carbon skeleton derives from the unusual C7 α,ω-dicarboxylic acid, pimelic 
acid (1). Pioneering studies identified the intermediates involved in forming the fused bicyclic 
structure that have been shown to be conserved in all bacterial species 2-5. E. coli has proved a 
useful model organism to study biotin biosynthesis and sequencing of the genomic locus, the 
“bio operon”, revealed five genes (bioA, bioB, bioF, bioC and bioD) involved in biotin 
formation 6. Four of the five genes encode highly conserved enzymes that catalyse the 
conversion of pimeloyl-CoA to biotin (8-amino-7-oxononanoate synthase (AONS, bioF gene 
product), diaminononanoate synthase (DANS, bioA gene product), dethiobiotin synthetase 
(DTBS, bioD gene product) and biotin synthase (BS, bioB gene product, Fig. 1a) 7. The x-ray 
structures and catalytic mechanisms of the E. coli AONS, DANS, DTBS and BS enzymes have 
been reported 8-13.  
In contrast to the early biosynthetic steps, the origin of pimelic acid varies across bacterial 
species, and has been found in various forms: as a free di-acid, a mono-methyl ester, and 
transformed into a pimeloyl thioester by attachment to either coenzyme A (CoASH) or an acyl 
carrier protein (ACP) 14. The thioester is condensed with L-alanine in an AONS-catalysed 
reaction to begin the late stages of biotin biosynthesis 8, 13. Labelling studies using 13C acetate 
provided insight into the origin of the carbon atoms of pimeloyl-CoA and biotin in E. coli 15, 
16. Two enzymes from the biotin pathway, BioC (a SAM-dependent methyltransferase) and 
BioH (an esterase), hijack fatty acid biosynthesis by methylating malonyl-ACP, then extending 
it through two rounds of the fatty acid synthase cycle 17. The crystal structure of an inactive 
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BioH S82A mutant:pimeloyl-ACP methyl ester complex revealed the origin of the acyl-chain 
length specificity 18.  
In Bacillus subtilis, the presence of genes encoding BioI and BioW enzymes has suggested that 
this microbe makes and processes the pimelic acid precursor differently from E. coli 19. BioI 
shows homology to cytochrome P450 enzymes but is able to complement biotin production in 
bioC or bioH mutant E. coli strains. Subsequently, crystal structures of BioI captured in 
complex with acyl-ACPs of varying chain lengths have provided a mechanistic understanding 
of how heme chemistry is used to act upon the acyl chain and generate pimelic acid 20, 21. BioW 
from Bacillus sphaericus has been characterised to have pimeloyl-CoA synthetase activity (EC 
number 6.2.1.14) 22, 23. This homolog displays high sequence identity to the predicted enzyme 
in B. subtilis so it is somewhat surprising that this enzyme was not characterised until recently 
24. BioW uses pimelic acid and MgATP to generate a pimeloyl-adenylate intermediate which 
subsequently reacts with CoASH to give the acyl-CoA thioester product (Fig. 1a). The BioW 
reaction is highly specific to pimelic acid; mono- and di-acids of different chain lengths are 
either not processed at all or are hydrolysed at the acyl-adenylate stage in a proofreading 
manner 24. Whilst this ensures that only the correct vitamin is made in vivo rather than 
potentially toxic analogues with shorter and/or longer chains, it represents an unfortunate 
limitation for biotechnological applications. It also suggests that BioW has been under great 
selective pressure to accept only pimelic acid, since biotin vitamers with different chain lengths 
have never been isolated. 
The activation of carboxylic acids as adenylates is a common strategy in nature and exemplified 
in the ANL superfamily of adenylating enzymes that includes the acyl-CoA synthetases 25, 26. 
The carboxylate of biotin is also adenylated by a biotin protein ligase (BPL) for final transfer 
to the lysine side chain of carboxylases 27. The mechanism involves the attack of the 
carboxylate at the α-phosphate of ATP to form the adenylate, driven by pyrophosphate (PPi) 
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elimination (Fig. 1a). The proposed transition state is the negatively charged, penta-coordinate 
trigonal bipyramidal phosphorous atom, which is common to other triphosphate nucleotide 
utilising enzymes including kinases and DNA polymerases 26. Interestingly a structural link 
between kinases and one type of adenylase has been identified 28. Sequence analysis of the B. 
subtilis BioW showed no homology with other known adenylases or ATP-dependent 
synthetases, suggesting it may represent another member of the adenylase enzyme superfamily.  
Here we present structural and mechanistic studies of B. subtilis BioW and reveal that it extends 
the number of folds capable of catalysing adenylation. It is the C-terminal domain that 
recognises pimelic acid with exquisite specificity, thus controlling entry into the biotin 
biosynthetic pathway. Structure-guided mutagenesis was used to generate an enzyme that can 
processes a range of fatty acid substrates, unlocking the synthetic potential of this enzyme for 
the production of acyl-CoAs. The ability to generate acyl-CoA thioesters through biocatalytic 
methods would be extremely valuable since they are used as substrates in studies of important 
metabolic enzymes such as those involved in fatty acid biosynthesis 29.  
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RESULTS 
B. subtilis BioW isolation and assay 
In contrast to previous studies 24 we found that a 6xHis-tag positioned at the N-terminus of B. 
subtilis BioW (Supplementary Results, Supplementary Fig. 1a, b and c), allowed the 
isolation of milligram amounts of active enzyme. By HPLC and mass spectrometry 
(Supplementary Fig. 2) we confirmed that BioW converted pimelic acid (C7 dicarboxylic 
acid, 1), MgATP and CoASH to pimeloyl-CoA (2), eluting at 16.2 minutes, with a mass of 
910.1865 Da (M+H+, expected 910.1855 for C28H46N7O19P3S) and AMP. For all 
crystallisation, native mass spectrometry and substrate specificity assays the His-tag was 
removed and the resultant enzyme was a homodimer (Supplementary Fig. 1c). 
For enzyme kinetics we modified a commercially-available (ENZCHECK), coupled assay 
(pyrophosphatase (PPase), purine nucleoside phosphorylase (PNP)) which links PPi formation 
in the first half of the reaction to the formation of a colorimetric product detectable at 360 nm 
(Supplementary Fig. 3 30, 31). We also monitored acyl-CoA thioester bond formation at 230 
nm 23 and observed pimeloyl-CoA (2) product formation by HPLC and mass spectrometry. The 
coupled assay proved to be more useful than the 230 nm assay due to lower background 
absorbance. We used the coupled assay to determine the kinetic parameters for the BioW 
substrates pimelic acid (Km = 70.5 ± 6.8 µM; kcat = 0.48 ± 0.02 s-1) and ATP (299.6 ± 37.6 µM, 
kcat = 0.44 ± 0.03 s-1) and the 230 nm assay used to measure the value for CoASH (229.3 ± 25.4 
µM, kcat = 0.87 ± 0.05 s-1) (Supplementary Fig. 4, Supplementary Table 1). We observed 
substantially higher enzyme activity than previously reported for pimelic acid (~0.480 s-1 
compared with 8.4 × 10-5 s-1) 24 and our results are comparable with that observed for the B. 
sphaericus BioW; Km pimelate (145 µM), ATP (170 µM), CoASH (33 µM) and a kcat of 0.4 s-
1 23. We also used the coupled assay to determine relative activities (based on the kcat) of 
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dicarboxylic acid substrates of various carbon chain lengths (C5, glutaric acid (3); C6, adipic 
acid (4); C8, suberic acid (5); C9, azelaic acid (6)). This confirmed that the wild-type enzyme 
is highly specific for the native substrate since the kcat values (0.0051 s-1 for 3, 0.0066 s-1 for 4, 
0.0038 s-1 for 5 and 0.0001 s-1 for 6) were all ≤1% compared with pimelic acid (0.480 s-1) (Fig. 
1b and Supplementary Table 2). Importantly, very little activity (with large errors) was 
detected with both the monocarboxylate substrates heptanoic acid (7, 0.0016 s-1) and octanoic 
acid (8, 0.0020 s-1) with wild-type BioW (Fig. 1b and Supplementary Table 2). 
 
Structural analysis of BioW 
The asymmetric unit of BioW is a homodimer (Fig. 2a), and analysis with the PISA server 32 
identified that the observed dimer is stable, burying approximately 900 Å2 of surface area per 
monomer. The crystal structure was consistent with native mass spectrometry and gel filtration 
experiments. Each monomer consists of two domains, a small 70 residue N-terminal domain 
and a larger C-terminal domain (Fig. 2b). The N-terminal domain has a three-stranded anti-
parallel β-sheet (β1-3) with an α-helix lying on one face. The dimer interface is confined to 
the N-terminal domain that brings together the β3 strands of each monomer such that the dimer 
has a 6 stranded antiparallel β-sheet. In addition to these main chain hydrogen bonds, there are 
a few additional polar and hydrophobic interactions that involve the α-helix (α1). 
Superimposing monomers reveals that the relative orientation of domains differs within each 
monomer, suggesting the linkage between the domains is flexible. The C-terminal domain has 
a central, predominantly anti-parallel seven-stranded β-sheet; each face of the sheet has two α-
helices and one of the helices (α5) stacks against a small two stranded parallel β-sheet (β4 and 
13) (Fig. 2b). The domain has a fifth helix (α4) that packs against the loop of the C-terminus. 
Analysis with PDB fold does not identify other enzymes with this fold, suggesting the structure 
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represents an extension to the ANL family of enzymes known to catalyse the adenylation 
reaction 26. This family currently contains three classes (I-III) and so we propose BioW as the 
first representative of class IV. 
Two co-complexes, pimeloyl-adenylate plus PPi (Fig. 2c and Supplementary Fig. 5a) and 
AMP-PNP plus pimelic acid (Supplementary Fig. 5b and 5c) localize the active site almost 
entirely within the C-terminal domain and identify the residues in contact with ATP and 
pimelic acid. Although the AMP-PNP could be expected to be active (since the enzyme breaks 
the α-β not the β-γ bond) the inactivity of this derivative has been observed before 33. In both 
complexes the adenosine and ribose rings, the β and γ phosphates and the two Mg2+ ions are 
located in essentially identical positions making the same contacts with the protein (Fig. 2d 
and 2e and Supplementary Fig. 5a, 5b, 5d and 5e). The adenosine ring sits in a pocket with 
the side chain of Arg145 stacking on its face; the ring itself makes two hydrogen bonds to the 
main chain at Val146, a hydrogen bond to Glu31 and to a network of water molecules. The 
ribose ring hydrogen bonds to Arg227, the main chain of Val122 and to the network of water 
molecules. Comparing the atoms at the α phosphate in both complexes reveals that the 
phosphorous atom has shifted less than 1.0 Å and the three oxygen atoms that remain are 
unaffected by bond breaking/making and have shifted less than 0.2 Å. Two of these oxygen 
atoms are each bound to a different Mg2+ ion, the third oxygen atom which connects to the 
ribose ring is salt bridged to Arg227. 
Combining the complexes reveals that the α oxygen-phosphorous bond which connects to the 
β-phosphate makes an angle of 180° with the oxygen atom that links the α phosphorous to the 
carboxylate of pimelic acid (Fig. 2d). From these structures, a model of the penta-covalent 
bipyramidal transition state can be constructed. The carboxyl-adenylate bond sits between 
Ser194 on one side and on the other side two water molecules (denoted W1 and W2) which are 
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hydrogen bonded to each other (Fig. 2e). The Ser194 side chain is hydrogen bonded to the 
protein main chain. The hydrogen bond network of these water molecules is extensive but 
neither is ideally positioned to attack the carbonyl. W1 is bound to the guanidyl group of 
Arg227, which would be predicted to lower the nucleophilicity of the water, whilst W2 is 
hydrogen-bonded to W1 and would require some re-arrangement to be correctly positioned for 
attack. In the adenylate complex Arg170 is hydrogen bonded to the pimelic acid carboxylate 
oxygen atom that is not linked to the phosphorous. In contrast, in the enzyme complex with 
AMP-PNP and pimelic acid, the carboxylate group is in a different orientation and not aligned 
for attack at the α phosphate (Supplementary Fig. 5b). The carboxylate makes a different salt 
bridge to Arg170 and hydrogen bonds to Ser194 as well as water molecules ligated to the Mg2+ 
ions. The β and γ phosphate groups bind two Mg2+ ions, the β phosphate makes interactions 
with the N-terminal domain side chains of His26 and Arg145 and the γ phosphate makes 
contacts with the side chains of Lys49 and His53. The Mg2+ ions both have octahedral 
coordination and are ligated by three phosphate oxygen atoms. One Mg2+ ion has three bound 
water molecules and the other Mg2+ ion binds to the side chains of Asp195, Asp196 and one 
water to complete the coordination shell. 
Pimelic acid binds in an elongated tunnel (Supplementary Fig. 5d and 5e) and the carboxylate 
group at the C7 (ω) position, that does not react with ATP is anchored in both structures by a 
salt bridge to Arg213, as well as forming hydrogen bonds to two tyrosine side-chains (Tyr199 
and Tyr211, Figs. 2e and Supplementary Fig. 5d). There are some small differences in the 
precise conformation of the alkyl chains between the two structures that arise from the different 
location of the reactive carboxylate (C1, α) in the two subunits. Despite this, in both structures 
the alkyl chain makes contacts (< 4.0 Å) along its length with the enzyme such that any 
substitution of hydrogens with larger heteroatoms would result in clashes.  
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A crystal of the enzyme with CoASH and pimelic acid has density for two pimelic acid 
molecules but only one CoASH (Fig. 2f and Supplementary Fig. 5f and 5g). There is 
however no reliable density for the pantetheine arm (only the adenine, ribose and three 
phosphates clearly defined). CoASH is bound close to the dimer interface where it interacts 
with the strands of the N-terminal domain. The adenine ring makes a hydrogen bond to Glu66 
from the other subunit, whilst the 3-phosphate is bound by a cluster of three Arg residues 
(Arg13, Arg123, Arg145). A surface plot (Supplementary Fig. 5h) of the complex reveals 
two possible tunnels that reach from the CoASH binding sites to the pimelic acid. One tunnel 
is formed by residues Arg11, Arg13, Glu31, Arg123 and Arg145, whilst the other is formed by 
His26, Arg55, Asp195. Although the ordered pyrophosphate group of CoASH points towards 
the first of these tunnels, the disorder of the pantothenate arm and the fact that the complex was 
obtained by soaking (thus restricting any conformational change) precludes a definitive 
assignment of the correct tunnel. The 5-pyrophosphate group does not make any hydrogen 
bonds. We suggest that due to the two fold non-crystallographic axis, were a second molecule 
of CoASH to be bound, the terminal 5′ phosphates of the CoASH would be closer than 4.0 Å. 
 
Native mass spectrometry analysis of BioW 
We used native ESI-MS analysis to detect BioW-bound intermediates 34 and observed charge 
state distributions consistent with monomeric and dimeric protein (Fig. 3a). Deconvolution of 
the +14 charge state is consistent with the mass of the ligand-free BioW dimer (Fig 3a,b, 
observed m/z = 4233.9, theoretical m/z = 4233.6).  
Upon addition of pimelic acid and MgATP, we observed two species, a dominant mass of m/z 
= 4304.0 consistent with the formation of a BioW dimer: pimeloyl-adenylate complex with 2:2 
stoichiometry (mass difference 980.7 Da, Fig. 3c) and a smaller peak corresponding to a single 
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pimeloyl-adenylate bound to the dimer (m/z = 4268.9). When BioW was mixed with pimelic 
acid, MgATP and CoASH we observed an increase in the relative abundance of the BioW 
dimer with only one pimeloyl-adenylate bound (m/z = 4269.0) and also of the ligand-free BioW 
(m/z = 4234.4) (Fig. 3d). We only observed ions consistent with the binding of the pimeloyl-
adenylate and failed to detect BioW complexes with either pimelic acid, MgATP, PPi or the 
product pimeloy-CoA bound. This suggested that the BioW: pimeloyl-adenylate intermediate 
complex is highly stable and is broken down in the presence of CoASH. 
 
Residues controlling substrate binding and catalysis 
Structural data and multiple sequence alignment of BioW isoforms (Supplementary Fig. 6) 
guided the selection of four residues for mutagenesis (Tyr199, Tyr211, Arg213, Arg227). Each 
BioW mutant was expressed and purified in a similar manner to the wild type enzyme. We 
measured enzyme activity (turnover) using the PPi release-based coupled assay with saturating 
concentrations of the acid, MgATP and CoASH and set the wild-type BioW activity (kcat, s-1) 
as 100%. Mutants R227E and R227K showed reduced BioW turnover with the natural substrate 
pimelic acid by around 20 fold (~4% activity remaining) (Fig. 4a). The R213A mutation 
reduced BioW activity >99% compared with wild type and was effectively inactive. In contrast, 
mutant Y199F retained 55% activity and similarly, mutant Y211F retained 36% activity (Fig. 
4a). 
The wild type BioW displays high specificity for pimelic acid with much reduced turnover 
observed (kcat value ≤1%) with both shorter and longer dicarboxylic acids substrates (3, 4, 5 
and 6, Fig. 1b, Fig. 4b, Supplementary Table 2). Both Y199F and Y211F mutants displayed 
reduced or barely detectable turnover compared to the WT BioW with shorter chain length 
substrates glutaric acid and adipic acid (Fig. 4b). In contrast, these mutants displayed increased 
12 
 
activity relative to wild type BioW with the longer dicarboxylic acid substrates suberic acid 
and azelaic acid (Fig. 4b). Using an increased enzyme concentration of 3.0 µM we observed 
that the Y199F mutant displayed a two-fold improved activity with but no improvement with 
azelaic acid over wild type (Supplementary Fig. 7). In contrast, the Y211F mutant displayed 
~4 fold increased activity with the suberic acid substrate and ~3 fold increased activity with 
the azelaic acid substrate relative to the wild-type BioW (Supplementary Fig. 7).  
The BioW crystal structure with CoASH bound (albeit without clear density for the 
phosphopantetheine arm) identified the side-chains of Arg11 and Arg13 as potentially involved 
in binding the phosphate groups of this substrate and we generated mutants at these two sites 
(R11A and R13A). Both mutants were essentially inactive with pimelic acid (Supplementary 
Fig. 8, <1.0 % activity compared with WT).  
 
An engineered BioW displays novel activity 
The wild-type BioW enzyme displayed little activity when incubated with heptanoic acid and 
octanoic acid at both low (0.1 µM) and high (3.0 µM) enzyme concentrations respectively (Fig. 
4b and Supplementary Fig. 7). Similarly, the Y199F mutant was also inactive with heptanoic 
acid and octanoic acid (Fig. 4b and Supplementary Fig. 7). In contrast, the Y211F displayed 
activity with both monocarboxylic acid substrates at 0.1 µM concentration (Fig. 4b) and at the 
higher concentration (3.0 µM) the Y211F mutant displayed a kcat of 0.012 ± 0.001 s-1 and 0.008 
s-1 with heptanoic acid and octanoic acid respectively (Supplementary Fig. 7) Indeed, turnover 
was such that we could determine the Km for heptanoic (529.0 ± 79.7 µM) and ATP (479.4 ± 
81.5 µM) (Supplementary Fig. 9). We set up “synthetic reactions” by incubation of the wild 
type and the Y211F mutant enzyme (5.0 µM) with saturating concentrations of heptanoic acid, 
MgATP and CoASH for 5 hours at 30 oC. HPLC analysis showed that the wild type BioW 
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produced no detectable product (Fig. 5a). In contrast, the BioW Y211F mutant generated a 
peak eluting at 20.3 minutes (Fig. 5a) which was confirmed as the heptanoyl-CoA (9) thioester 
product using mass spectrometry (Fig. 5b, predicted mass for C28H48N7O17P3S [M+H]+ = 
880.2113 Da, observed mass = 880.2124 Da). It is worth noting that despite producing no 
detectable product with pimelic acid, we found that the BioW R213A mutant did give rise to 
detectable amounts of the heptanoyl-CoA and octanoyl-CoA (10) (Supplementary Fig. 7).  
Since the BioW Y211F mutant displayed novel heptanoyl-CoA synthetase activity we tested 
whether it could also accept fatty acid substrates substituted at the reduced end of the acyl 
chain. Five commercially available derivatives (7-bromoheptanoic acid, 11; 7-aminoheptanoic 
acid, 12; 6-methylheptanoic acid, 13; 7-phenylheptanoic acid, 14 and 7-octenoic acid, 15) were 
screened using a convenient LC-MS method to detect the formation of the corresponding acyl-
CoA products (Supplementary Figs. 10 a-f). We observed product formation for all of the 
substrates apart from the 7-aminoheptanoic acid derivative confirming the broadened synthetic 
utility of the BioW Y211F mutant.  
 
DISCUSSION 
An early step in biotin biosynthesis requires the AONS-catalysed condensation of L-alanine 
and a thioester activated form of pimelic acid (either pimeloyl-CoA or pimeloyl-acyl carrier 
protein (ACP), Fig. 1a). We found that BioW is highly specific for pimelic acid, turning over 
this substrate at least 100 times faster than either adipic acid or suberic acid.  
The fatty acid specificity of BioW is controlled by a cluster of residues that bind to and fix the 
position of the ω- carboxylate of pimelic acid while the carbon chain sits in a hydrophobic 
tunnel (Fig. 2e and Supplementary Fig. 5d and 5e). Only when the intervening seven carbon 
atoms adopt an extended conformation will the other (α) carboxylate group be appropriately 
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positioned to attack the α-phosphate of ATP required to generate the pimeloyl-adenylate. Since 
the tunnel is restricted in volume and the ω position fixed, additional carbons will result in 
clashes with ATP and shorter chains will not reach it. We identified this internal ruler as the 
origin of the chain length selectivity of BioW. 
Superposition of the ligand-bound BioW structures revealed that the geometry of the incoming 
nucleophilic oxygen atom of the carboxylate and the phosphate is ideal for addition to form the 
pentavalent phosphorus transition state (Fig. 2d). We suggest Arg227 and Arg170 stabilise the 
negative charge on the oxygen atom of the carboxylate enhancing its nucleophilicity. In the 
AMP-PNP analog structure, we identified two Mg2+ ions that will bridge the α and γ phosphates 
of ATP and in doing so each Mg2+ binds to and stabilises the terminal oxygen atom of the α 
phosphate in the transition state. In the BioW:pimeloyl-adenylate:PPi complex the two Mg2+ 
ions bind to and, we presume, stabilise the negatively charged PPi leaving group.  
We found that PPi release (and thus activity in our coupled assay) only occurs in a substantial 
amount when CoASH is bound to the enzyme (Supplementary Fig. 9). Mutation of predicted 
CoASH binding residues (Arg11, Arg13) stopped turnover even in the presence of CoASH 
(Supplementary Fig. 9). Such a tight coupling would be desirable in vivo since futile 
consumption of ATP would be deleterious to the cell. Since ATP and pimelic acid bind to the 
protein in the absence of CoASH, these data suggested either the adenylate does not form in 
the absence of CoASH or that the adenylate is stable until CoASH binds. We favour the latter 
explanation as, in the absence of CoASH, we observed the adenylate intermediate in crystals 
(Fig. 2c) and by native mass spectrometry (Fig. 3). Adenylates are usually highly reactive, as 
exemplified in studies of biotin protein ligase (BPL), which generates the biotin-adenylate 
intermediate that is used to transfer biotin onto the biotin carrier domain of ACC. Mutation of 
a key arginine in BPL releases the adenylate intermediate, allowing it to biotinylate in a 
promiscuous manner 35, 36, and this has been used in biotin proximity assays (named BioID) 37. 
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The BioW assay had a detectable background rate without CoASH suggesting water can 
hydrolyse the adenylate (Supplementary Fig. 9). The adenylate intermediate, although bound 
in the enzyme, is not shielded from solvent with water molecules positioned close to the 
carboxylate group (Fig. 2e). We suggest that the positioning and hydrogen bonding of the water 
molecules means they cannot rapidly hydrolyse the adenylate and this accounted for the very 
unusual stability of the adenylate intermediate. 
In a crystal soaked with CoASH, all but the pantothenate arm was located experimentally and 
mutagenesis at the ribose phosphate binding site supported our assignment that this is where 
CoASH binds (Fig. 2f). BioW possesses two possible tunnels from the surface to the catalytic 
site that could be consistent with the pantothenate arm reaching in to attack the adenylate (Fig. 
6 and Supplementary Fig. 5h). To form the thioester bond, the thiol group must displace at 
least one water molecule at the adenylate and since thiols are generally regarded as stronger 
nucleophiles than water, we suggest the thiol is sufficiently reactive to decompose the 
adenylate in the presence of Arg227. It has been proposed that class I-III ANL enzymes 
undergo large conformational changes during their catalytic cycle, the C-terminal domain 
rotates in relation to the N-terminus in the presence of CoASH 25, 38. We did not observe any 
such large conformational changes in the class IV BioW, but we cannot exclude such a 
mechanism. 
Thioesters are chemically synthesised in an analogous way to the enzymatic process; typically 
by acid activation (e.g. as acid anhydrides or acid chlorides), then reaction with an appropriate 
thiol. Older methods are low-yielding and the di-acids have to be protected to direct synthesis 
of mono-thioester targets. Alternative methods such as iron-catalysed coupling of aldehydes 
with sulfur surrogates 39 and methyl acyl phosphates have been developed 40, but a “green” 
biocatalytic synthesis of simple fatty acid thioesters would be highly desirable. The relatively 
simple catalytic domain of BioW provided an ideal template to engineer an enzyme with 
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expanded substrate range. Having defined the chain length specificity and the “internal ruler” 
(Fig. 2e), we made mutants at Tyr199 and Tyr211 that trimmed back H-bond donors and side 
chains that mediate electrostatic interactions. We found that the BioW Y211F mutant retained 
activity with pimelic acid and gained the ability to synthesise heptanoyl-CoA from heptanoic 
acid (Fig. 5). We saw no evidence that the adenylate intermediate is released into solution 
suggesting that the mutant enzyme has retained the ability to stabilise the non-cognate 
adenylate intermediate.  
Encouraged by the gain of function of BioW Y211F, we tested a variety of fatty acid derivatives 
modified at the terminus of the acyl chain and found that the enzyme was able to convert four 
of the five substrate analogues into the corresponding acyl-CoA thioester product 
(Supplementary Fig. 10). This result exemplified the synthetic utility of a BioW mutant to 
generate useful acyl-CoA products. A promiscuous acyl-ACP synthetase (AasS) from Vibrio 
harveyi has also been used to attach various fatty acid substrates to ACPs 41. With its expanded 
substrate range, our BioW Y211F mutant is a useful addition to the toolkit that enables enzyme-
catalysed preparation of these useful chemical building blocks. BioW is a relatively small 
enzyme, with few residues defining the active site, so we propose that this new member of the 
ANL superfamily (the first class IV member) offers great scope to expand the range of acyl-
thioesters that can be synthesised. Exemplifying this idea, the BioW R213A mutant accepted 
octanoic acid, suggesting that the active site can be further exploited and engineered to accept 
longer acyl chains. Applying the tools of directed evolution and combining these with the 
application of a high-throughput assay for acyl-CoA thioester formation activity would allow 
the full synthetic potential of BioW to be explored 42. 
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Figure Legends 
 
Figure 1. The BioW reaction highlighting its role in biotin biosynthesis and the activity of 
wild type BioW with various fatty acid substrates. (A) The enzyme pimeloyl-CoA 
synthetase (BioW) catalyses the conversion of pimelic acid to the pimeloyl-CoA thioester via 
the pimeloyl-adenylate intermediate. In the next step the condensation of pimeloyl-CoA with 
L-alanine is catalysed by the pyridoxal 5’-phosphate (PLP)-dependent enzyme 8-amino-7-
oxononanoate synthase (AONS). The product of this reaction, 8-amino-7-oxononanoate, is 
then converted to 7,8-diaminononanoate (DAN) by the PLP-dependent transaminase 
diaminononanoate synthase (DANS). The ureido ring of dethiobiotin is formed by the enzyme 
dethiobiotin synthease (DTBS). The final step involves the insertion of sulfur and is catalysed 
by the enzyme biotin synthase (BS). AMP is adenosine monophosphate. (B) The PPi release 
assay was used to determine enzyme activity and is based on turnover (kcat, s-1) in the presence 
of BioW (0.1 µM), ATP (1.0 mM) and CoASH (1.0 mM) and carboxylic acids (1.5 mM) of 
various carbon chain lengths. The best BioW substrate is pimelic acid (C7; 1) and the worst is 
azelaic acid (C9; 6). Data represent mean values ± s.d. from multiple experiments. 
 
Figure 2. Structural biology of BioW. (A) Overall structure of the BioW dimer. The AMP-
PNP and pimelic acid molecules are shown as sticks (carbon in yellow, oxygen in red, nitrogen 
in blue and phosphate in orange). The protein A and B subunits are colored green and blue, 
respectively. The N-terminal domain is highlighted by a dashed box. 
(B) Overall structure of BioW monomer. Secondary structure elements are labelled and 
coloured red (α-helices), yellow (β-sheets) and green (loops). AMP-PNP and pimelic acid are 
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shown as sticks (carbon atoms in white, other atoms as in (a)), and Mg2+ ions are shown as 
green spheres. 
(C) Fo-Fc electron density omit map at 3 σ around the pimeloyl-adenylate. Compounds are 
shown as sticks with carbon atoms colored cyan, other atoms as (a). 
(D) Superposition of the pimeloyl-adenylate / PPi and AMP-PNP / pimelic acid complexes. 
For clarity, the protein has been removed. Carbon atoms are coloured in cyan (pimeloyl-
adenylate) and yellow (AMP-PNP/pimelic acid), other atoms as (a). The superposition allows 
a model for the pentavalent phosphorous transition state to be deduced. 
(E) The pimeloyl-adenylate is stable, despite two water molecules (W1 and W2) being 
positioned close to the adenylate ester carbonyl group. The hydrogen bonding network and 
positioning of waters inhibits their ability to attack the ester. 
(F) Binding site of the adenosine 3', 5'-diphosphate group of CoA. Residues within 4.0 Å of 
the CoA are displayed. Carbon atoms of the CoA are pink and residues of A and B subunits 
are light cyan and white. 
 
Figure 3. Native mass spectrometry analysis of BioW. (A) BioW is observed as a monomer 
(charge states 12+ to 9+) and a dimer (charge states 16+ to 13+) by native mass spectrometry 
when ionised from 200 mM ammonium bicarbonate buffer. The 14+ charge state dimer species 
[boxed in (A) and expanded in (B)], has observed m/z = 4233.9 and is in good agreement with 
the theoretical m/z = 4233.6. (C) Incubation of BioW with 1.0 mM pimelic acid and 1.0 mM 
MgATP led to the formation of a 14+ ion with m/z = 4304.0. This mass difference (980.7 Da) 
is consistent with non-covalent binding of two molecules of pimeloyl-adenylate (theoretical 
mass 489.4 Da). (D) Addition of 0.5 mM CoASH to the incubation described in (C) led to an 
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increase in the intensity of the ion with m/z = 4269.0 which is consistent with one molecule of 
pimeloyl-adenylate. 
 
Figure 4. Activity of wild type BioW and active site mutants towards pimelic acid and 
assays to determine the chain length specificity of BioW and designed mutants. (A) The 
pyrophosphate (PPi) release assay was used to determine enzyme activity and is based on 
turnover (kcat, s-1) in the presence of BioW enzyme (0.1 µM, WT and mutant), pimelic acid (1.5 
mM), ATP (1.0 mM), CoASH (1.0 mM). The value for WT BioW (0.48 s-1) was set at 100% 
and the BioW mutant values are shown relative to WT. (B) The turnover (kcat, s-1) of the BioW 
WT enzyme and each of the mutants Y199F, Y211F and R213A (0.1 µM) in the presence of 
different mono- and dicarboxylic acids (compounds 3, 4, 5, 6, 7, 8, 1.5 mM), ATP (1.0 mM) 
and CoASH (1.0 mM). The WT BioW data with pimelic acid (0.48 s-1) is included for 
comparison. Data represent mean values ± s.d. from multiple experiments. 
 
Figure 5. Synthesis of hepatonyl-CoA by the engineered BioW Y211F mutant. The WT 
BioW enzyme and Y211F mutant were incubated with the heptanoic acid, ATP and CoASH 
substrates for 5 hours at 30 oC before analysis by HPLC. The heptanoyl-CoA product elutes at 
20.3 minutes. No detectable product is observed using the WT BioW. (B) The peak eluting at 
20.3 minutes was collected and confirmed as C7-CoA by FT-ICR Mass spectrometry 
(predicted mass for C28H48N7O17P3S [M+H]+ = 880.2113 Da, observed 880.2124 Da). The 
expertimental mass spectrum shown (m/z range = 878-886) matches that predicted (the red dots 
are the isotope distribution based on the chemical formula) and the inset is the full mass 
spectrum (m/z range = 0-2500). 
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Figure 6. Schematic of the BioW active site. The key residues in the C-terminal domain 
involved in pimelic acid recognition (Tyr199, Tyr211 and Arg213) are highlighted, as are those 
involved in pimeloyl-adenylate binding (Arg170, Arg227). The N-terminal residues involved 
in coenzyme A (CoASH) binding (Arg11 and Arg13) are included, as is the PPi derived from 
ATP and the coordinating Mg2+ ions. We propose formation of the pimeloyl-CoA thioester 
product by attack of the adenylate intermediate by the thiol of the incoming CoASH. 
 
ONLINE METHODS 
Reagents 
Standard chemical reagents (pimelic acid or other dicarboxylic acids, mono- fatty acids, ATP, 
buffers) and enzymes were from Sigma, Alfa Aesar and Acros Organic. CoASH was from 
Chem-Impex International. UV-transparent plates were from Costar.  
 
Cloning, expression and purification 
The full-length, codon-optimised bioW gene (Bacillus subtilis (strain 168), UNIPROT code: 
P53559) was purchased from GenScript and cloned into two expression plasmids to give 
recombinant BioW with a non-cleavable N-terminal 6His tag (pET-28a) and a pEHISTEV 
plasmid which gives an N-terminal tobacco etch virus (TEV) protease-cleavable His6 tag 43. 
The B. subtilis bioW gene was expressed in E. coli BL21 (DE3) transformed with the 
appropriate plasmid and 2 L LB media were grown in 500 ml shake flasks until the OD600 
reached 0.6-0.8. Expression was induced with 0.1 mM IPTG and the cells were grown at 30 °C 
for 4 h. All purification steps were performed at 4 °C or on ice. Cells were resuspended in lysis 
buffer (20 mM sodium phosphate pH 7.5, 500 mM NaCl, 10 mM imidazole, 2 mM TCEP, 10% 
glycerol with the addition of complete EDTA-free protease inhibitor tablets (Roche), DNase 
(0.2 mg per 10 mL buffer) and lysozyme (1 mg per 10 mL buffer,) and lysed with a cell 
disruptor at 30 kPSI (Constant Systems Ltd). The crude lysate was cleared by centrifugation 
(45,000 g, 4 °C, 30 min), filtered through a 0.22 µm filter and loaded onto a 5ml His-trap (GE 
Healthcare) column attached to an AKTA system. The column was washed with the same lysis 
buffer without the protease inhibitor tablet and DNase. The BioW was eluted with an increasing 
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imidazole gradient (25-300 mM) over 20 column volumes (100 ml). Eluted BioW was dialysed 
against 1L of 50 mM Tris-HCl pH 8.0, 500 mM NaCl, 2 mM β-mercaptoethanol (BME), 10% 
glycerol, 0.25 mM PMSF for 1h. Where appropriate (e.g. for crystallisation), the His6 tag was 
cleaved by incubation with TEV protease (mass ratio 1:15) overnight. The uncleaved protein 
and protease were then removed by passage through a second HisTrap column in lysis buffer 
containing 20 mM imidazole. Finally, the BioW (6His-tagged or TEV-cleaved) was loaded 
onto a gel filtration Superdex 200 column (GE Healthcare) in 10 mM Tris-HCl pH 8.0, 150 
mM NaCl, 0.25 mM PMSF, 1 mM dithiothreitol (DTT). After His6 tag removal, the BioW N-
terminus contains the sequence GAMEEE. Each step of the purification was monitored by 
SDS-PAGE and the masses of both His6 BioW and TEV-cleaved BioW were confirmed by LC 
ESI-MS analysis. 
 
Site-directed and site-saturation mutagenesis. 
The BioW mutants Y199F, Y211F and R213A were constructed according to the overlapping 
primer site-directed mutagenesis method 44 with the following primers pairs. 
 
Y199F 
Y199F forward (5′-
ATGCTGGTCGGACGATCCGGATTTCATAACAGGCTATGTTGCGGGTAAGAAAAT
GGGCTAT-3′) 
Y199F reverse (5′-
CTTACCCGCAACATAGCCTGTTATGAAATCCGGATCGTCCGACCAGCATAATTCT
GCAACG-3′) 
 
Y211F 
Y211F forward (5′-
ATGTTGCGGGTAAGAAAATGGGCTTCCAGCGTATTACAGCAATGAAAGAATACG
GGACTG-3′) 
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Y211F reverse (5′-
CTTTCATTGCTGTAATACGCTGGAAGCCCATTTTCTTACCCGCAACATAGCCTGTT
ATG-3′) 
 
R213A 
R213A forward (5′-
GCGGGTAAGAAAATGGGCTATCAGGCAATTACAGCAATGAAAGAATACGGGAC
TGAAG-3′) 
R213A reverse (5′-
CCCGTATTCTTTCATTGCTGTAATTGCCTGATAGCCCATTTTCTTACCCGCAACAT
AG-3′). 
 
R11A 
R11A forward (5′-
GAAGAAACTTTTTATAGTGTCGCTATGAGGGCTTCAATGAATGGATCTCATGAAG
ACGGCGG-3′) 
R11A reverse (5′-
GAGATCCATTCATTGAAGCCCTCATAGCGACACTATAAAAAGTTTCTTCTTCCAT
GG-3′) 
 
R13A 
R13A forward (5′-
GAAGAAACTTTTTATAGTGTCAGAATGGCTGCTTCAATGAATGGATCTCATGAAG
ACGGCGG-3′) 
R13A reverse (5′-
GAGATCCATTCATTGAAGCAGCCATTCTGACACTATAAAAAGTTTCTTCTTCCAT
GG-3′) 
 
R227E and R227K 
The BioW mutants R227E, R227K were generated by saturation mutagenesis with the 
following primers: 
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R227X forward (5′-
ATACGGGACTGAAGAGGGCTGCRMAGTCTTTTTTATTGATGGCTCCAATGATGTA
AACA-3′) 
R227X reverse (5′-
GGAGCCATCAATAAAAAAGACTKYGCAGCCCTCTTCAGTCCCGTATTCTTTCATT
GCTG-3′) 
Where R = A/G, M = A/C, K = G/T, Y = C/T. 
Colonies were picked, sequenced and based on the results BioW mutants R227E and R227K 
were taken forward for analysis. All BioW point mutant proteins were overexpressed with 0.5 
mM IPTG at 20 °C overnight. The purification protocol is the same as the His6 tagged wild 
type protein with TEV protease removal of the His tag. The mass of each BioW mutant was 
confirmed by LC electrospray ionization mass spectrometry (ESI-MS). 
 
Enzyme assays 
Monitoring of acyl-CoA thioester bond formation. 
Measurements were made by a previously described continuous UV spectrophotometric assay 
23. This assay is based on monitoring the formation of the acyl-CoA thioester bond at 230 nm. 
The BioW enzyme (0.2 μM) in 100 mM Tris-HCl pH 8.5, 200 mM NaCl, 10 mM MgCl2 was 
incubated at 30 °C with 0.4 mM CoASH, 0.4 mM ATP in a reaction volume of 200 μL The 
reactions were started by the addition of 1.5 mM pimelic acid and the 230 nm absorbance was 
recorded for 30 minutes on a BioTek Synergy HT plate reader with Costar 96-well UV-
transparent plates. The rate over the first 10 minutes was analysed using the Michaelis-Menten 
model and a nonlinear regression fit on GraphPad to give values of Km and kcat. 
 
Pyrophosphate (PPi) production assay. 
The BioW activity was also determined by monitoring the release of PPi via a two enzyme 
coupled assay. The final volume of the reactions was 200 μL and contained 50 mM Tris-HCl 
pH 8.0, 100 mM NaCl, 10 mM MgCl2, 1.0 mM triscarboxyethylphosphine (TCEP), 0 to 1.0 
mM CoASH, 0 to 1.0 mM ATP, 0.5 mM 7-methyl-6-thioguanosine (MESG, Berry & 
Associates), 0.03 U of inorganic pyrophosphatase (PPase from baker’s yeast, Sigma), 1 U of 
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bacterial purine nucleoside phosphorylase (PNP, Sigma) and 0.1 μM BioW enzyme (or up to 
3.0 μM for several mutants). These reagents were pre-incubated at 30 °C for 15 min and the 
reaction was initiated by adding 0 to 1.5 mM pimelic acid (or dicarboxylic acids or fatty acid 
substrates of varying carbon chain length). The increase in absorbance at 360 nm resulting from 
the enzymatic conversion of MESG to 7-methyl-6-thioguanine (ε360= 11,000 M-1cm-1) was 
monitored over 30 min on a BioTek Synergy HT plate reader with Costar 96-well UV-
transparent plates. The data from the first 10 minutes was analysed using the Michaelis-Menten 
model and a nonlinear regression fit on GraphPad gave values of Km and kcat. 
 
High Performance Liquid Chromatography (HPLC) analysis of acyl-CoA formation. 
The formation of acyl-CoA esters was detected by an HPLC method. The reactions contained 
25 mM Tris-HCl pH 8.0, 50 mM NaCl, 5 mM MgCl2, 0.2 mM TCEP, 1.5 mM CoASH, 1.5 
mM ATP, 5.0 μM BioW and 1.5 mM mono- or dicarboxylic acid substrate (and substituted 
derivatives) were incubated at 30 °C in a final volume of 500 μL. The reactions were terminated 
at varying time points by incubation with acetonitrile (0.1% TFA, (trifluoroacetic acid)) 
(volume ratio 1:1). The samples were clarified by centrifugation at 17, 000 x g for 10 minutes 
and filtered through a 0.45 μm filter. 10 to 50 μL of the sample was then injected onto Luna 5μ 
C18(2) RP-HPLC column (100A, 250x4.60mm, Phenomenex),and eluted with water (0.1% 
TFA v/v) for 5 min followed by a 15 min gradient from 5% to 55% acetonitrile (0.1% TFA, 
v/v)/water (0.1% TFA, v/v) which was maintained for 5 min, returning to 100% water (0.1% 
TFA) for the final five minutes. The eluant was monitored at 260 nm and where necessary the 
peak containing the acyl-CoA product was collected and concentrated under reduced pressure 
(to remove TFA and acetonitrile) and heating at 35 °C. Samples were either resuspended or 
diluted into further into water and analysed by FT-ICR Mass Spectrometry on a 12 Tesla 
SolariX FT-ICR MS (Bruker Daltronics) via positive electrospray ionisation. For MS, samples 
were co-injected with ESI-L Low Concentration Tuning Mix (Agilent Technologies, G1969-
85000). Synthetic pimeloyl-CoA standard was prepared using a published method 45.  
 
Mass spectrometry analysis of acyl-CoA products 
2.5 μL of the BioW incubated with various fatty acids (see HPLC analysis above) was injected 
onto a Kinetex 5μm C18 reverse phase column (100Å, 50x2.1mm, Phenomenex) and eluted at 
0.5ml/min with buffers A (0.1% v/v formic acid) and B (acetonitrile, 0.1% v/v formic acid). 
The samples were loaded and washed with 0.5% buffer A for 5 min before switching from 
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waste to MS and running a gradient from 0.5% to 55% buffer B, followed by column washing 
and equilibration. Electrospray ionisation was coupled to a Synapt G2 Q-TOF (Waters) with a 
120 °C source temperature, 2kV capillary voltage, and sampling cone voltage of 35. MS spectra 
were acquired over a 150-2000 mass range in positive polarity and in sensitivity mode. A 
lockmass correction was applied once at the beginning of each analysis against Leucine 
Enkephalin peptide. 
 
Crystallization and Structure Determination 
Crystals of BioW appeared at 4°C after a week from a hanging drop of 1 μl of protein solution 
(19 mg.ml-1, 5.0 mM pimelic acid, 1.0 mM MgCl2 and 5.0 mM ATP, AMP-PNP or BrATP) 
with 1 μl of reservoir solution containing 26 % PEG 400, 0.1 M HEPES pH 7.5 in vapor 
diffusion with reservoir. For phasing, crystals were soaked in 50 mM K2PtCl4 for 
approximately 15 minutes and back-soaked in mother liquor containing pimelic acid, ATP and 
MgCl2. Crystals crystalized in the presence of BrATP were soaked overnight in a crystallisation 
solution containing 20 mM CoASH and 5 mM pimelic acid before been flash frozen. BrATP 
was not present in the crystal structure but a residual density in the chain A active site has been 
modelled as a PEG400 molecule. Data were collected at 100 °K at the Diamond light source 
Oxfordshire, beamlines IO3 (λ=1.07206), IO4 (λ=0.97949) and IO2 (λ=0.9795) for K2PtCl4, 
AMP-PNP/pimelic acid and pimelic acid/CoASH complexes respectively. For the Pimeloyl-
adenylate/PPi complex, data were collected in house using a Rigaku MicromaxTM-007HF Cu 
anode with VariMax optics and Rigaku Saturn 944+ CCD detector. Data were processed with 
XIA2 46-50 or HKL2000 51. Phases were determined by SAD and an initial model built using 
the Crank pipeline 52 as implemented in CCP4i2 53 and the structure refined with REFMAC5 
and adjusted with COOT 54 and Autobuild program of PHENIX 55. 
Subsequent structures were solved by molecular replacement with the program PHASER 56 
using the coordinates from the experimental structure. Final models were adjusted with COOT 
54 and refinement was carried out using REFMAC in the CCP4 program suite with NCS 
restraints and TLS parameters 57. Final refinement statistics are given in Supplementary Table 
3. Atomic coordinates and structure factors have been deposited in the Protein Data Bank 
(5fm0, 5flg, 5fll, 5g1f). Coordinates and topologies of ligands were generated by PRODRG 58. 
The quality of all structures were checked with MOLPROBITY 59. The Ramachandran 
statistics are as followed: 98.6% favored and 1.4% allowed for K2PtCl4; 100% favored for the 
AMP-PNP/pimelic acid complex; 99.2% favored and 0.8% allowed for the pimeloyl-
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adenylate/PPi complex; 98.3% favored and 1.7% allowed for the pimelic acid/CoASH 
complex. Figures were drawn using PYMOL 60.  
 
Native Mass Spectrometry 
The BioW sample was desalted twice over P6 Micro Bio-Spin columns (Bio-Rad) into 200 
mM ammonium bicarbonate and further diluted to approximately 20 µM (10 µM dimer). 
Native MS spectra were acquired before and after addition of 1.0 mM MgATP, 1.5 mM pimelic 
acid and 0.5 mM CoASH. Samples were infused by nano-electrospray ionisation (nano-ESI) 
using a TriVersa NanoMate (Advion) set at 1.6 kV and 0.8 psi pressure. Electrospray was 
coupled to a Synapt G2 Q-TOF (Waters) with the source set at 80 oC, backing pressure 
increased to 5 mbar, and sampling cone voltage of 150 V. Spectra were averaged over 4 minutes 
of acquisition data and presented without further data processing. Peak m/z annotations were 
extracted from smoothed and centroided using Waters MassLynx V4 software. 
 
Data Availability 
Crystallographic X-Ray crystal structures of all BioW structures reported have been deposited 
in the Protein Data Bank under accession codes: 5fm0 (BioW:K2PtCl4 soak), 5flg (BioW-
AMP/PNP/pimelic acid), 5fl1 (BioW: pimeloyl-adenylate/PPi), 5g1f (BioW: pimelic 
acid/CoASH soak). The research data supporting this publication can be accessed at Datashare 
[http://dx.doi.org/10.7488/ds/1560]. 
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